132MO Zanidatamab (ZW25; Zani) in patients (pts) with previously treated advanced human epidermal growth factor receptor 2 (HER2)-amplified biliary tract cancer (BTC): Asia subgroup analysis of the phase IIb HERIZON-BTC-01 study

Hsin‐Yun Sun, D-Y. Oh, Jing Ma et al.|Annals of Oncology|2023

Cited by 0